Personalized precision medicine

References

[1] Garrett WS. The gut microbiota and colon cancer. Science 2019;364:1133–5.10.1126/science.aaw2367Suche in Google Scholar PubMed

[2] Donia MS, Fischbach MA. Human microbiota. Small molecules from the human microbiota. Science 2015;349:1254766.10.1126/science.1254766Suche in Google Scholar PubMed PubMed Central

[3] Cani PD. Gut cell metabolism shapes the microbiome. Science 2017;357:548–9.10.1126/science.aao2202Suche in Google Scholar PubMed

[4] Nobs SP, Elinav E. Walk on the wildling side. Science 2019;365:444–5.10.1126/science.aay2864Suche in Google Scholar PubMed

[5] Rosshart SP, Herz J, Vassallo BG, Hunter A, Wall MK, Badger JH, et al. Laboratory mice born to wild mice have natural microbiota and model human immune responses. Science 2019;365:eaaw4361.10.1126/science.aaw4361Suche in Google Scholar PubMed PubMed Central

[6] Bleich RM, Arthur JC. Revealing a microbial carcinogen. Science 2019;363:689–90.10.1126/science.aaw5475Suche in Google Scholar PubMed

[7] Muir A, Vander Heiden MG. The nutrient environment affects therapy. Science 2018;360:962–3.10.1126/science.aar5986Suche in Google Scholar PubMed PubMed Central

[8] Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 2018;555:210–5.10.1038/nature25973Suche in Google Scholar PubMed

[9] O’Neill C. Gut microbes metabolize Parkinson’s disease drug. Science 2019;364:1030–1.10.1126/science.aax8937Suche in Google Scholar PubMed

[10] Goetz LH, Schork NJ. Personalized medicine: motivation, challenges, and progress. Fertil Steril 2018;109:952–63.10.1016/j.fertnstert.2018.05.006Suche in Google Scholar PubMed PubMed Central

[11] Maughan T. The promise and the hype of ‘personalised medicine’. New Bioeth 2017;23:13–20.10.1080/20502877.2017.1314886Suche in Google Scholar PubMed PubMed Central

[12] Haigis KM, Cichowski K, Elledge SJ. Tissue-specificity in cancer: the rule, not the exception. Science 2019;363:1150–1.10.1126/science.aaw3472Suche in Google Scholar PubMed

[13] Ablain J, Xu M, Rothschild H, Jordan RC, Mito JK, Daniels BH, et al. Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma. Science 2018;362:1055–60.10.1126/science.aau6509Suche in Google Scholar PubMed PubMed Central

[14] Ledford H. Five big mysteries about CRISPR’s origins. Nature 2017;541:280–2.10.1038/541280aSuche in Google Scholar PubMed

[15] Amitai G, Sorek R. Intracellular signaling in CRISPR-Cas defense. Science 2017;357:550–1.10.1126/science.aao2210Suche in Google Scholar PubMed

[16] Zimmermann M, Murina O, Reijns MA, Agathanggelou A, Challis R, Tarnauskaitė Ž, et al. CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions. Nature 2018;559:285–9.10.1038/s41586-018-0291-zSuche in Google Scholar PubMed PubMed Central

[17] Knott GJ, Doudna JA. CRISPR-Cas guides the future of genetic engineering. Science 2018;361:866–9.10.1126/science.aat5011Suche in Google Scholar PubMed PubMed Central

[18] Scott A. A CRISPR path to drug discovery. Nature 2018;555:810–1.10.1038/d41586-018-02477-1Suche in Google Scholar PubMed

[19] Mosteiro L, Pantoja C, Alcazar N, Marión RM, Chondronasiou D, Rovira M, et al. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo. Science 2016;354:aaf4445.10.1126/science.aaf4445Suche in Google Scholar PubMed

[20] Ma H, Marti-Gutierrez N, Park SW, Wu J, Lee Y, Suzuki K, et al. Correction of a pathogenic gene mutation in human embryos. Nature 2017;548:413–9.10.1038/nature23305Suche in Google Scholar PubMed

[21] Klaeger S, Heinzlmeir S, Wilhelm M, Polzer H, Vick B, Koenig PA, et al. The target landscape of clinical kinase drugs. Science 2017;358:eaan4368.10.1126/science.aan4368Suche in Google Scholar PubMed PubMed Central

[22] Venot Q, Blanc T, Rabia SH, Berteloot L, Ladraa S, Duong JP, et al. Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature 2018;558:540–6.10.1038/s41586-018-0217-9Suche in Google Scholar PubMed PubMed Central

[23] Semple RK, Vanhaesebroeck B. Lessons for cancer drug treatment from tackling a non-cancerous overgrowth syndrome. Nature 2018;558:523–5.10.1038/d41586-018-05365-wSuche in Google Scholar PubMed

[24] Konieczny L, Roterman I, Spólnik P. Systems biology. Dordrecht: Springer, 2013.10.1007/978-3-319-01336-7Suche in Google Scholar

[25] Manfredi C, Tindall JM, Hong JS, Sorscher EJ. Making precision medicine personal for cystic fibrosis. Science 2019;365:220–1.10.1126/science.aaw0553Suche in Google Scholar PubMed PubMed Central

[26] Sievers QL, Petzold G, Bunker RD, Renneville A, Słabicki M, Liddicoat BJ, et al. Defining the human C₂H₂ zinc finger degrome targeted by thalidomide analogs through CRBN. Science 2018;362:eaat0572.10.1126/science.aat0572Suche in Google Scholar PubMed PubMed Central

[27] Snyder EY. Finding a new purpose for old drugs. Science 2017;357:869–70.10.1126/science.aao2992Suche in Google Scholar PubMed

[28] Manning BD. Signalling protein protects the heart muscle from pressure-related stress. Nature 2019;566:187–8.10.1038/d41586-019-00245-3Suche in Google Scholar PubMed

[29] Ranek MJ, Kokkonen-Simon KM, Chen A, Dunkerly-Eyring BL, Vera MP, Oeing CU, et al. PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress. Nature 2019;566:264–9.10.1038/s41586-019-0895-ySuche in Google Scholar PubMed PubMed Central

[30] Servick K. Unexpected drug emerges for stroke recovery. Science 2019;363:805.10.1126/science.363.6429.805Suche in Google Scholar PubMed

[31] Couzin-Frankel J. Anti-inflammatory prevents heart attacks. Science 2017;357:855.10.1126/science.357.6354.855Suche in Google Scholar PubMed

[32] Hejtmancik JF. Cataracts dissolved. Nature 2015;523:540–1.10.1038/nature14629Suche in Google Scholar PubMed

[33] Couzin-Frankel J. Second chapter. Science 2016;353:983–5.10.1126/science.353.6303.983Suche in Google Scholar PubMed

[34] Xu M, Pokrovskii M, Ding Y, Yi R, Au C, Harrison OJ, et al. c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont. Nature 2018;554:373–7.10.1038/nature25500Suche in Google Scholar PubMed PubMed Central

[35] Munn LL, Jain RK. Vascular regulation of antitumor immunity. Science 2019;365:544–5.10.1126/science.aaw7875Suche in Google Scholar PubMed PubMed Central

[36] McKinney EF, Lee JC, Jayne DR, Lyons PA, Smith KG. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature 2015;523:612–6.10.1038/nature14468Suche in Google Scholar PubMed PubMed Central

[37] Clouthier DL, Ohashi PS. Costimulation, a surprising connection for immunotherapy. Science 2017;355:1373–4.10.1126/science.aan1467Suche in Google Scholar PubMed

[38] Bryant VL, Hodgkin PD. Life, death, and antibodies. Science 2017;358:171–2.10.1126/science.aap8728Suche in Google Scholar PubMed

[39] Jagusiak A, Rybarska J, Piekarska B, Stopa B, Konieczny L. Self-assembled molecules – new kind of protein ligands – supramolecular ligands. In: Roterman I, Konieczny L, editor. Springer Open, 2018:21–42.10.1007/978-3-319-65639-7_2Suche in Google Scholar PubMed

[40] Zemanek G, Jagusiak A, Rybarska J, Piwowar P, Chłopaś K, Roterman I. Self-assembled molecules – new kind of protein ligands. In: Roterman I, Springer Open, 2018:43–60.10.1007/978-3-319-65639-7_3Suche in Google Scholar PubMed

[41] Jiang Y, Sun A, Zhao Y, Ying W, Sun H, Yang X, et al. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature 2019;567:257–61.10.1038/s41586-019-0987-8Suche in Google Scholar PubMed

[42] Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 2018;359:926–30.10.1126/science.aar3247Suche in Google Scholar PubMed PubMed Central

[43] Kalinich M, Haber DA. Cancer detection: seeking signals in blood. Science 2018;359:866–7.10.1126/science.aas9102Suche in Google Scholar PubMed PubMed Central

[44] Martinez-Jimenez CP, Eling N, Chen HC, Vallejos CA, Kolodziejczyk AA, Connor F, et al. Aging increases cell-to-cell transcriptional variability upon immune stimulation. Science 2017;355:1433–6.10.1126/science.aah4115Suche in Google Scholar PubMed PubMed Central

[45] Niccoli T, Partridge L. Ageing as a risk factor for disease. Curr Biol 2012;22:R741–52.10.1016/j.cub.2012.07.024Suche in Google Scholar PubMed

[46] Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. Geroscience: linking aging to chronic disease. Cell 2014;159:709–13.10.1016/j.cell.2014.10.039Suche in Google Scholar PubMed PubMed Central

[47] Campisi J, Kapahi P, Lithgow GJ, Melov S, Newman JC, Verdin E. From discoveries in ageing research to therapeutics for healthy ageing. Nature 2019;571:183–92.10.1038/s41586-019-1365-2Suche in Google Scholar PubMed PubMed Central

[48] Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. Aging: a common driver of chronic diseases and a target for novel interventions. Cell 2014;159:709–13.10.1016/j.cell.2014.10.039Suche in Google Scholar

[49] Nowell PC. Discovery of the Philadelphia chromosome: a personal perspective. J Clin Invest 2007;117:2033–5.10.1172/JCI31771Suche in Google Scholar PubMed PubMed Central

[50] Steketee RW, ter Kuile F. Single low-dose primaquine to reduce malaria transmission. Lancet Infect Dis 2014;14:91–2.10.1016/S1473-3099(13)70288-3Suche in Google Scholar PubMed